Search hospitals > Nebraska > Kearney
Heartland Hematology and Oncology
Claim this profileKearney, Nebraska 68845
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
101 reported clinical trials
2 medical researchers
Summary
Heartland Hematology and Oncology is a medical facility located in Kearney, Nebraska. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Heartland Hematology and Oncology is involved with conducting 101 clinical trials across 319 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage III
2Lung Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
172 reported clinical trials
239 drugs studied
Mehmet S. CopurBethesda North Hospital12 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
2 reported clinical trials
8 drugs studied
Clinical Trials running at Heartland Hematology and Oncology
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Ovarian Tumors
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Cancer
Laryngeal Cancer
Germ Cell Tumors
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Heartland Hematology and Oncology?
Heartland Hematology and Oncology is a medical facility located in Kearney, Nebraska. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Heartland Hematology and Oncology is involved with conducting 101 clinical trials across 319 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.